Home > Authorities > Institutes > Record #113726 |
G330
KKE Molekulare Hämatologie/OnkologieID | I:(DE-He78)G330-20160331 |
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |
Journal Article
Comprehensive genomic profiling - Chancen der molekularen Diagnostik am Beispiel des Portfolios von Foundation Medicine.
Thieme drug report -, 3-11 (2018)
BibTeX |
EndNote:
XML,
Text |
RIS
Contribution to a book
Enasidenib
Small Molecules in Hematology / Martens, Uwe M. (Editor) ; Cham : Springer International Publishing, 2018, Chapter 9 ; ISSN: 0080-0015=2197-6767 ; ISBN: 978-3-319-91438-1=978-3-319-91439-8 ; doi:10.1007/978-3-319-91439-8
Cham : Springer International Publishing, Recent Results in Cancer Research 212, 187 - 197 (2018) [10.1007/978-3-319-91439-8_9]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Karzinome mit unklarer Primärlokalisation – CUPISCO‑StudieCarcinoma of unknown primary – CUPISCO trial
Forum 33(5), 376 - 377 (2018) [10.1007/s12312-018-0503-3]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article (Review Article)
Hematological malignancies in adults with a family predisposition.[Hämatologische Neoplasien im Erwachsenenalter mit familiärer Prädisposition].
Deutsches Ärzteblatt international 115(50), 848-854 (2018) [10.3238/arztebl.2018.0848]
BibTeX |
EndNote:
XML,
Text |
RIS
Dissertation / PhD Thesis
The influence of centrosome amplification and clustering on cell migration and invasion
Dissertation, Universität Heidelberg, 2018
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
CD7 is expressed on a subset of normal CD34-positive myeloid precursors.
European journal of haematology 101(3), 318 - 325 (2018) [10.1111/ejh.13100]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myeloma.
Blood advances 2(20), 2607 - 2618 (2018) [10.1182/bloodadvances.2018023200]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial.
The lancet <London> / Oncology Oncology 19(12), 1668-1679 (2018) [10.1016/S1470-2045(18)30580-1]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article (Letter)
JAM-C Expression as a Biomarker to Predict Outcome of Patients with Acute Myeloid Leukemia-Letter.
Cancer research 78(21), 6339-6341 (2018) [10.1158/0008-5472.CAN-18-0642]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via enhanced CtBP1 association.
Nucleic acids symposium series 46(15), 7662 - 7674 (2018) [10.1093/nar/gky536]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |